Secukinumab in psoriasis: A single-center experience
Background and Design: Several randomized clinical trials demonstrated the safety and efficacy of secukinumab in the systemic treatment of moderate-severe psoriasis; however, real-life data is limited. Thus, this study aimed to assess the efficacy and safety of secukinumab in patients with psoriasis...
Saved in:
Main Authors: | Esra Ağaoğlu (Author), Hilal Kaya Erdoğan (Author), Ersoy Acer (Author), Zeynep Nurhan Saraçoğlu (Author), Muzaffer Bilgin (Author) |
---|---|
Format: | Book |
Published: |
Galenos Publishing House,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of anxiety sensitivity in patients with psoriasis
by: Hilal Kaya Erdogan, et al.
Published: (2019) -
Urticaria due to acitretin in a patient with lichen planus
by: Hilal Kaya Erdogan, et al.
Published: (2020) -
Secukinumab in psoriasis patients with prior ustekinumab treatment: Results of a single-center experience
by: Ting-Shun Wang, et al.
Published: (2017) -
The efficacy and safety of phototherapy in geriatric patients: a retrospective study
by: Isil Bulur, et al.
Published: (2018) -
Methotrexate Treatment in Children with Febrile Ulceronecrotic Mucha-Habermann Disease: Case Report and Literature Review
by: Isil Bulur, et al.
Published: (2015)